Sign Up to like & get
recommendations!
0
Published in 2024 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noae064.224
Abstract: Abstract BACKGROUND Ependymomas continue to be an aggressive brain tumor entity without targeted therapies. The highly recurrent fusion oncoprotein (FO), ZFTA-RELA, is known to be associated with about 70% of supratentorial ependymomas. While recent studies…
read more here.
Keywords:
zfta rela;
fusion oncoproteins;
zfta fusion;
zfta ... See more keywords